Blood
Blood
Tissue
Tissue
Marrow
Marrow
Texas Cord Blood Bank
Texas Cord
Blood Bank

April 2, 2012

Enterprise holding company created to encompass South Texas Blood & Tissue Center, QualTex Laboratories

Healthcare executive Dennis Fallen appointed to head the enterprise

SAN ANTONIO – The Board of Directors of the South Texas Blood & Tissue Center (STBTC) announced today it has created a new holding company that will oversee its two operating units, the South Texas Blood & Tissue Center and QualTex Laboratories, and its supporting foundation. The board also announced it has appointed Dennis K. Fallen as Chief Executive Officer of the holding company, which will encompass STBTC’s full range of blood and tissue services and QualTex Laboratories’ blood and plasma testing services.

The new organization that Fallen will lead is yet to be named. Dennis Stahl, chairman of the STBTC Board of Directors, explained that the board, along with the executive management of STBTC and QualTex, is working on a name that will reflect the organization’s wide range of capabilities in blood, tissue, bone marrow, cord blood, regenerative medicine, research and biologic testing. STBTC is asking the IRS to approve the new holding company as a non-profit, 501(c)(3) organization before it will become fully operational.

"We are blessed to have an outstanding president and chief operating officer at the helm of each of our operating units, the South Texas Blood & Tissue Center and QualTex Laboratories," Stahl said. Mary Beth Fisk serves as President and COO of STBTC and Executive Director of the Blood & Tissue Center Foundation, while Linda Kay Myers is President and COO of QualTex. "The board believes Dennis Fallen’s leadership experience with several premier biomedical organizations will provide the seasoned, broad-based management and planning expertise that our expanding organization needs to move boldly into the future," Stahl said.

Fallen had served as Vice President and General Manager of Fisher Bioservices since 2007. He will assume his new role on April 2. He defined strategic planning and brand strategy at Fisher BioServices, a world leader in biological specimen management supporting the pharmaceutical, biotech, academic and government markets. Previous work also included assignments at Baxter Healthcare and the American Red Cross. Fallen also is retired from the U.S. Navy, where he was a healthcare administrator in the Medical Service Corps.

"The South Texas Blood & Tissue Center and QualTex Laboratories are widely respected throughout the healthcare world," Fallen said. "They have spent years earning a reputation for extremely high quality, meticulous attention to detail, and always thinking of patient needs first. They are also developing exciting new plans for the future, and I am thrilled to have this opportunity to help lead these great organizations."

Follow Us